Prognos Health

This Valentine's Day, our hearts are with patients facing rare diseases like Transthyretin Amyloid Cardiomyopathy (ATTR-CM). This often underdiagnosed heart condition impacts thousands, but early intervention is key. Imagine the difference we could make with faster diagnosis and treatment. As part of our mission to unlock the power of data to improve health, Prognos Health empowers pharma and biotech companies dedicated to rare diseases like ATTR-CM by providing the comprehensive, high-quality data they need to accelerate their efforts. We help connect them with the right HCPs and patients, so they can bring hope and better outcomes to those who need it most. Ahead of Rare Disease Day (February 28th), let's recognize the power of data to transform lives. Join us in supporting the rare disease community. #RareDiseaseDay #ATTRCM #PrognosHealth #DataForGood #Pharma #Biotech #CommercialStrategy

Are you working in the hereditary angioedema (HAE) space? Prognos Health is sharing how our comprehensive lab data solutions can revolutionize your commercial strategies. We're helping teams enhance targeting, improve patient identification, and streamline operations, ultimately leading to better access to vital HAE therapies. Discover how data can drive your success and improve patient outcomes: https://bit.ly/4aXLDp0 #HAE #RareDisease #CommercialStrategy #DataInsights #PrognosHealth

Leading up to #RareDiseaseDay, Prognos Health reveals how our lab data insights empower a leading pharma company to reach HCPs treating acromegaly patients through weekly alerts, reporting a 6x increase in sales force effectiveness. This is part of our series highlighting how lab data can target HCPs treating patients in oncology and rare disease faster than other RWD methods. Follow us to learn more! Read today's post here: https://bit.ly/3EK1N9l #Acromegaly #Pharma #RWD #raredisease

Acute Myeloid Leukemia (AML) is a complex and aggressive cancer. Early diagnosis and treatment are critical. Learn how lab data can accelerate the identification of key HCPs involved in AML care, leading to faster connections and improved patient outcomes. Read more here: https://bit.ly/42OXhk1 #AML #LabData #RWD #oncology #raredisease

Excited to work with Throtle advancing Pinpoint HCP as part of our precision marketing suite. Check out the press release below!

🚀 Transforming the Landscape of Lysosomal Storage Disorder (LSD) Commercialization! Identifying and reaching the right HCPs and patients with LSDs, like Gaucher and Fabry disease, can be incredibly difficult. Traditional methods often fail, leading to wasted resources and missed opportunities. By leveraging real-world data (RWD), Prognos empowers commercial teams to pinpoint HCPs treating LSD patients, access real-time diagnostic insights, segment and target with precision, and optimize field force effectiveness. Prognos Health is transforming how pharmaceutical and biotech companies approach LSD commercialization. Read our latest blog post to learn more: https://bit.ly/3WEkvp7 #RareDiseases #LysosomalStorageDisorders #PharmaInnovation #PrognosHealth #PatientOutcomes

We're proud to sponsor DigiPharma Connect 2025, connecting pharma and biotech leaders in tackling digital transformation challenges. Learn more: https://lnkd.in/egspP6vh #DigiPharmaConnect2025 #DigiPharma2025

🎯 Prognos Health's Pinpoint HCP Audiences Now Available First Through Doceree! 🎯 We're excited to announce that Pinpoint HCP audiences from Prognos Health are now available first through Doceree! This means Doceree clients get exclusive first access to: - Unprecedented precision: Target HCPs based on specific lab values and patient conditions. - Real-time insights: Weekly updates on HCPs with newly diagnosed patients. - Enhanced accuracy: Go beyond ICD-10 codes for precise diagnoses. Improve your HCP targeting, optimize marketing campaigns, and drive better patient outcomes with Pinpoint HCP. Learn more about this exclusive partnership: https://bit.ly/4eEvk0v #HCPtargeting #labdata #precisionmarketing #lifesciences #healthcare #Doceree #PinpointHCP

Breast cancer treatment is constantly evolving. To ensure the right patients receive the right therapies at the right time, we need to understand the patient journey and engage with healthcare professionals (HCPs) effectively. Lab data is key! It provides valuable insights that can be used to: - Identify the specific type and stage of cancer - Understand patient response to different therapies - Develop targeted drug development and personalized treatment strategies - Create more effective marketing campaigns Want to learn more about how lab data can improve breast cancer treatment? Read our latest blog post: https://bit.ly/4dnTkV1 #breastcancer #breastcancertreatment #labdata #HCPengagement #patientjourney

Are you a commercial leader or brand marketer based in Boston and focused on rare disease and/or oncology? Join Prognos Health for an exclusive half-day event on Tuesday, October 15th, 2024 in Boston to learn how to leverage real-world lab data for faster, more precise HCP identification and engagement. 💡 Gain insights from a panel of industry experts on: - Identifying and engaging HCPs treating complex patient populations - Better leveraging real-world data to optimize HCP targeting - Accelerating commercial launches in rare disease, oncology, and other complex clinical populations 🥂 Network with colleagues over cocktails and appetizers after the session. Space is limited! 👉 Register now: https://bit.ly/3MEgziX #HCPengagement #raredisease #oncology #realworlddata